BMJ 1995;310:171-175 (21 January)
Education and debate
Fortnightly Review: Irritable bowel, irritable body, or irritable brain?
Michael J G Farthing,
professor of gastroenterology aa Digestive Diseases Research Centre, Medical College of St Bartholomew's Hospital, London EC1M 6BQ
|
Summary points
- The irritable bowel syndrome affects about 20% of adults in the industrialised world
- The condition is a disturbance of gastrointestinal function of unknown cause, but abnormalities of intestinal motility and visceral sensation are found in some patients
- Symptoms of the irritable bowel syndrome are often associated with extraintestinal manifestations, including urinary symptoms, dyspareunia, and fatigue
- Overall, 40-60% of patients with the irritable bowel syndrome who seek medical advice have psychological symptoms of depression or anxiety, or both
- Diagnosis of the irritable bowel syndrome can usually be made on the basis of clinical history and examination, but exclusion of organic disease is advisable in patients aged >45 years who present with new bowel symptoms
- No uniformly successful treatment exists for the irritable bowel syndrome. End organ treatment aimed at relieving abdominal pain (antispasmodic drugs) or disturbed bowel habit (antidiarrhoeal and bulking agents) can produce symptomatic relief, and "central" treatment (for example, anti-depressants, hypnotherapy, psychotherapy) should be considered in patients with associated affective disorders
|

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Relevant Article
-
Food intolerance may play a part
- Peter J Lewis
BMJ 1995 310: 1067.
[Extract]
[Full Text]
This article has been cited by other articles:
-
Spence, M. J, Moss-Morris, R.
(2007). The cognitive behavioural model of irritable bowel syndrome: a prospective investigation of patients with gastroenteritis. Gut
56: 1066-1071
[Abstract]
[Full text]
-
Haugaard, J. J.
(2004). Recognizing and Treating Uncommon Behavioral and Emotional Disorders in Children and Adolescents Who Have Been Severely Maltreated: Somatization and Other Somatoform Disorders. Child Maltreat
9: 169-176
[Abstract]
-
Gunn, M C, Cavin, A A, Mansfield, J C
(2003). Management of irritable bowel syndrome. Postgrad. Med. J.
79: 154-158
[Abstract]
[Full text]
-
Lievre, M.
(2002). Alosetron for irritable bowel syndrome. BMJ
325: 555-556
[Full text]
-
Blomhoff, S., Spetalen, S., Jacobsen, M. B., Malt, U. F.
(2001). Phobic Anxiety Changes the Function of Brain-Gut Axis in Irritable Bowel Syndrome. Psychosom. Med.
63: 959-965
[Abstract]
[Full text]
-
AKEHURST, R, KALTENTHALER, E
(2001). Treatment of irritable bowel syndrome: a review of randomised controlled trials. Gut
48: 272-282
[Abstract]
[Full text]
-
Dixon-Woods, M., Critchley, S.
(2000). Medical and lay views of irritable bowel syndrome. Fam Pract
17: 108-113
[Abstract]
[Full text]
-
Bennett, E J, Evans, P, Scott, A M, Badcock, C-A, Shuter, B, Hoschl, R, Tennant, C C, Kellow, J E
(2000). Psychological and sex features of delayed gut transit in functional gastrointestinal disorders. Gut
46: 83-87
[Abstract]
[Full text]
-
Burke, P., Elliott, M., Fleissner, R.
(1999). Irritable Bowel Syndrome and Recurrent Abdominal Pain: A Comparative Review. Psychosomatics
40: 277-285
[Abstract]
[Full text]
-
Chassany, O, Marquis, P, Scherrer, B, Read, N W, Finger, T, Bergmann, J F, Fraitag, B, Geneve, J, Caulin, C
(1999). Validation of a specific quality of life questionnaire for functional digestive disorders. Gut
44: 527-533
[Abstract]
[Full text]
-
Castagliuolo, I., Wershil, B. K., Karalis, K., Pasha, A., Nikulasson, S. T., Pothoulakis, C.
(1998). Colonic mucin release in response to immobilization stress is mast cell dependent. Am. J. Physiol. Gastrointest. Liver Physiol.
274: G1094-G1100
[Abstract]
[Full text]
-
Gorard, D., Maxwell, P, Mendall, M, Hambidge, D M, Barber, R, Blakey, A, Neal, K R, Hebden, J, Spiller, R C
(1997). Prevalence of gastrointestinal symptoms after bacterial gastroenteritis. BMJ
314: 1902-1902
[Full text]